Finance

Lists
Why is IFRX down 5.00%?
Dive Deeper
IFRX:NASDAQ
Inflarx NV
$1.71
-5.00%
(-0.090) 1D
$1.71
0.00% (0.00)
After hours
Closed: Oct 1, 3:52:48 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IFRX...
Open
$1.83
High
$1.86
Low
$1.71
Mkt. cap
252.00M
Avg. vol.
696.19K
Volume
304.45K
52-wk high
$2.94
52-wk low
$0.80
EPS
-$0.57
Beta
2.52
Shares outstanding
147.37M
No. of employees
65
Open
$1.83
High
$1.86
Low
$1.71
Mkt. cap
252.00M
Avg. vol.
696.19K
Volume
304.45K
52-wk high
$2.94
52-wk low
$0.80
EPS
-$0.57
Beta
2.52
Shares outstanding
147.37M
No. of employees
65
News stories
From web sources and news partners
About Inflarx NV
CEONiels C. Riedemann
Employees65
Founded2007
Headquarters-
SectorBiotechnology
Websiteinflarx.de
Analyst ratings
Based on 5 analysts giving stock ratings to IFRX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for IFRX in the last 3 months.
Highest
Current $1.71
$9.00 (+426.32%)
Average
$7.20 (+321.05%)
Lowest
$5.00 (+192.40%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Stringer
Needham
Buy
Initiated
$8.00
+367.8%
09/14/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$6.00
+250.9%
08/06/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
$5.00
+192.4%
08/06/2026
Matthew Keller
H.C. Wainwright
Buy
Reiterated
$8.00
+367.8%
08/06/2026
Mazahir Alimohamed
Oppenheimer
Buy
Reiterated
$9.00
+426.3%
07/20/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
$9.00
+426.3%
06/30/2026
Ryan Deschner
Raymond James
Buy
Maintained
$9.00
+426.3%
05/13/2026
Yatin Suneja
Guggenheim
Buy
Maintained
$14.00
+718.7%
05/08/2026
Andreas Argyrides
Chardan Capital
Buy
Maintained
$5.00
+192.4%
04/24/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (EUR)
-€0.09 / -€0.06
-63.64%miss
Revenue / Est. (EUR)
- / 3.50K
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
23.83K
-33.93K
-
-
Cost of goods sold
333.00
4.86M
-
-
Cost of revenue
333.00
4.86M
-
-
Research and development expenses
6.24M
5.26M
4.17M
4.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.79M
3.36M
3.29M
2.58M
Operating expense
9.50M
7.97M
7.21M
7.32M
Total operating expenses
9.50M
12.83M
7.21M
7.32M
Operating income
-9.48M
-12.86M
-7.21M
-7.32M
Other non operating income
-3.17M
1.90M
803.16K
-7.91M
EBT including unusual items
-12.25M
-10.64M
-5.59M
-10.65M
EBT excluding unusual items
-12.25M
-10.64M
-5.59M
-10.91M
Income tax expense
12.28K
-
-
-
Effective tax rate
-0.10%
-
-
-
Other operating expenses
-528.70K
-649.05K
-247.91K
-2.11K
Net income
-12.26M
-10.64M
-5.59M
-10.65M
Net profit margin
-51,452.32%
31,364.81%
-
-
Earnings per share
-0.18
-0.15
-0.08
-0.09
Interest and investment income
438.13K
391.31K
334.77K
770.66K
Interest expense
-14.36K
-17.44K
-14.81K
-14.64K
Net interest expenses
423.78K
373.87K
319.96K
756.02K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.38M
-12.77M
-7.12M
-7.22M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps